These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 21708105

  • 1. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.
    Peyrin-Biroulet L, Khosrotehrani K, Carrat F, Bouvier AM, Chevaux JB, Simon T, Carbonnel F, Colombel JF, Dupas JL, Godeberge P, Hugot JP, Lémann M, Nahon S, Sabaté JM, Tucat G, Beaugerie L, Cesame Study Group.
    Gastroenterology; 2011 Nov; 141(5):1621-28.e1-5. PubMed ID: 21708105
    [Abstract] [Full Text] [Related]

  • 2. Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease.
    Singh H, Nugent Z, Demers AA, Bernstein CN.
    Gastroenterology; 2011 Nov; 141(5):1612-20. PubMed ID: 21806945
    [Abstract] [Full Text] [Related]

  • 3. Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis.
    Ariyaratnam J, Subramanian V.
    Am J Gastroenterol; 2014 Feb; 109(2):163-9. PubMed ID: 24419479
    [Abstract] [Full Text] [Related]

  • 4. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.
    Chakravarty EF, Michaud K, Wolfe F.
    J Rheumatol; 2005 Nov; 32(11):2130-5. PubMed ID: 16265690
    [Abstract] [Full Text] [Related]

  • 5. Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer.
    Scott FI, Mamtani R, Brensinger CM, Haynes K, Chiesa-Fuxench ZC, Zhang J, Chen L, Xie F, Yun H, Osterman MT, Beukelman T, Margolis DJ, Curtis JR, Lewis JD.
    JAMA Dermatol; 2016 Feb; 152(2):164-72. PubMed ID: 26510126
    [Abstract] [Full Text] [Related]

  • 6. Increased risk of acute myeloid leukemias and myelodysplastic syndromes in patients who received thiopurine treatment for inflammatory bowel disease.
    Lopez A, Mounier M, Bouvier AM, Carrat F, Maynadié M, Beaugerie L, Peyrin-Biroulet L, CESAME Study Group.
    Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1324-9. PubMed ID: 24582568
    [Abstract] [Full Text] [Related]

  • 7. Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study.
    Khan N, Abbas AM, Lichtenstein GR, Loftus EV, Bazzano LA.
    Gastroenterology; 2013 Nov; 145(5):1007-1015.e3. PubMed ID: 23891975
    [Abstract] [Full Text] [Related]

  • 8. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.
    Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, Hébuterne X, Cortot A, Bouhnik Y, Gendre JP, Simon T, Maynadié M, Hermine O, Faivre J, Carrat F, CESAME Study Group.
    Lancet; 2009 Nov 07; 374(9701):1617-25. PubMed ID: 19837455
    [Abstract] [Full Text] [Related]

  • 9. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.
    Mackenzie KA, Wells JE, Lynn KL, Simcock JW, Robinson BA, Roake JA, Currie MJ.
    Nephrol Dial Transplant; 2010 Jan 07; 25(1):300-6. PubMed ID: 19783601
    [Abstract] [Full Text] [Related]

  • 10. Nonmelanoma skin cancer after liver transplantation. Study of risk factors.
    Herrero JI, España A, Quiroga J, Sangro B, Pardo F, Alvárez-Cienfuegos J, Prieto J.
    Liver Transpl; 2005 Sep 07; 11(9):1100-6. PubMed ID: 16123952
    [Abstract] [Full Text] [Related]

  • 11. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.
    Long MD, Martin CF, Pipkin CA, Herfarth HH, Sandler RS, Kappelman MD.
    Gastroenterology; 2012 Aug 07; 143(2):390-399.e1. PubMed ID: 22584081
    [Abstract] [Full Text] [Related]

  • 12. Risk of skin cancer in patients with pterygium: a nationwide population-based cohort study in Taiwan.
    Yu HC, Lin CL, Chen ZT, Hu FR, Sung FC, Wang IJ.
    Ocul Surf; 2014 Jan 07; 12(1):69-76. PubMed ID: 24439048
    [Abstract] [Full Text] [Related]

  • 13. Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease.
    van Schaik FD, van Oijen MG, Smeets HM, van der Heijden GJ, Siersema PD, Oldenburg B.
    Gut; 2012 Feb 07; 61(2):235-40. PubMed ID: 21602529
    [Abstract] [Full Text] [Related]

  • 14. Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies.
    Beigel F, Steinborn A, Schnitzler F, Tillack C, Breiteneicher S, John JM, Van Steen K, Laubender RP, Göke B, Seiderer J, Brand S, Ochsenkühn T.
    Pharmacoepidemiol Drug Saf; 2014 Jul 07; 23(7):735-44. PubMed ID: 24788825
    [Abstract] [Full Text] [Related]

  • 15. The risk of non-melanoma skin cancer in New Zealand in inflammatory bowel disease patients treated with thiopurines.
    Bahi M, Walmsley RS, Gray AR, Young D, Hobbs CE, Aluzaite K, Schultz M.
    J Gastroenterol Hepatol; 2018 May 07; 33(5):1047-1052. PubMed ID: 29105142
    [Abstract] [Full Text] [Related]

  • 16. Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region.
    Bernat García J, Morales Suárez-Varela M, Vilata JJ, Marquina A, Pallardó L, Crespo J.
    Acta Derm Venereol; 2013 Jul 06; 93(4):422-7. PubMed ID: 23303600
    [Abstract] [Full Text] [Related]

  • 17. Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis.
    Amari W, Zeringue AL, McDonald JR, Caplan L, Eisen SA, Ranganathan P.
    Rheumatology (Oxford); 2011 Aug 06; 50(8):1431-9. PubMed ID: 21415022
    [Abstract] [Full Text] [Related]

  • 18. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
    Rodríguez-Acosta ED, Calva-Mercado JJ, Alberú-Gómez J, Vilatoba-Chapa M, Domínguez-Cherit J.
    Gac Med Mex; 2015 Aug 06; 151(1):20-6. PubMed ID: 25739480
    [Abstract] [Full Text] [Related]

  • 19. Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients.
    McLaughlin JM, Equils O, Somerville KT, Aram JA, Schlamm HT, Welch VL, Mardekian J, Barbers RG.
    Transpl Infect Dis; 2013 Aug 06; 15(4):329-43. PubMed ID: 23489832
    [Abstract] [Full Text] [Related]

  • 20. Nonmelanoma Skin Cancer Risk in Patients With Inflammatory Bowel Disease Undergoing Thiopurine Therapy: A Systematic Review of the Literature.
    Hagen JW, Pugliano-Mauro MA.
    Dermatol Surg; 2018 Apr 06; 44(4):469-480. PubMed ID: 29315147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.